International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
According to the latest report by IMARC Group, titled " PlantGenotypingEquipmentMarket:GlobalIndustryTrends,Share,Size,Growth,Opportunityand Forecast2022-2027
," the global plant genotyping equipment market reached a value of US$ 614.4 Million in 2021.
Plant genotyping equipment refers to the tool that is generally used for deoxyribonucleic acid (DNA) testing in plants and extracting high-quality DNA from the root, seed and leaf for reproducible DNA analysis. It is a vital process in the field of agricultural research that aid in studying seed quality control, plant genetics and crop trait development and improvement programs.
Along with this, it is also adopted for determining phenotype differences in plants as well as identifying relationships between individuals. Some of the common plant genotyping equipment that is utilized by scientific researchers include next-generation sequencing (NGS) methods and genotyping by sequencing (GBS).
Request for a PDF sample of this report: https://www.imarcgroup.com/plant-genotyping-equipment-market/requestsample
The global market is primarily driven by significant growth in biotechnology. Along with this, increasing investments by private and public agencies to upgrade the existing biotechnology infrastructure is providing a boost to the product demand. Moreover, continual technological advancements, such as the introduction of molecular markers and diversity array technologies, are creating a positive outlook for the market. Also, the widespread adoption of innovative farming practices is, in turn, fueling the sales of plant genotyping equipment. Furthermore, the escalating demand for agricultural products is acting as another growth-inducing factor. This is impelled by the changing dietary preferences, along with the scarce availability of arable lands, which is representing a major factor propelling the product demand across the globe. Other factors, including the increasing global population and the rising funding activities for conducting extensive research and development (R&D) activities in life sciences and nanotechnology for developing sophisticated sequencing tools, are further contributing to the market growth. Looking forward, IMARC Group expects the market is anticipated to reach a value of US$ 1,103.40 Millionby2027,exhibitingataCAGRof10.39%during2022-2027.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/plant-genotyping-equipment-market
Key Market Segmentation
The research report includes the following segments:
Breakup by Equipment:
• SNP Genotyping Equipment
• Real-time PCR Instrument
• DNA Analyzer
• Liquid Handler
• Others
Breakup by Application:
• Plant Research
• Breeding
• Product Development
• Quality Assessment
Breakup by End Use:
• Greenhouse
• Field
• Laboratory
Breakup by Region:
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
Competitive Landscape with Key Players:
• Agilent Technologies Inc
• BGI Genomics
• Eurofins Scientific
• Evogene Ltd
• Illumina Inc
• LGC Biosearch Technologies
• Merck KgaA
• Oxford Nanopore Technologies Limited
• PerkinElmer Inc
• Promega Corporation
• Thermo Fisher Scientific
1. Whatwasthesizeoftheglobalplantgenotypingequipmentmarketin2021?
2. Whatistheexpectedgrowthrateoftheglobalplantgenotypingequipmentmarketduring20222027?
3. Whatarethekeyfactorsdrivingtheglobalplantgenotypingequipmentmarket?
4. WhathasbeentheimpactofCOVID-19ontheglobalplantgenotypingequipmentmarket?
5. Whatisthebreakupoftheglobalplantgenotypingequipmentmarketbasedontheequipment?
6. Whatisthebreakupoftheglobalplantgenotypingequipmentmarketbasedontheapplication?
7. Whatisthebreakupoftheglobalplantgenotypingequipmentmarketbasedontheenduse?
8. Whatarethekeyregionsintheglobalplantgenotypingequipmentmarket?
9. Whoarethekeyplayers/companiesintheglobalplantgenotypingequipmentmarket?
Clickheretovisitthecompletetableofcontentwithlistoffiguresandtables: https://www.imarcgroup.com/plant-genotyping-equipment-market/toc
We are the trusted business partners to the world's leading corporates, governments, and institutions
We are the trusted business partners to the world's leading corporates, governments, and institutions
© 2022 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
